TG Therapeutics | Eiendeler



Assets Endring Dato
AbbVie USD 135.16B 8.26B 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Amgen USD 91.84B 956M 2024-12
Ardelyx USD 435.75M 67.89M 2024-12
Arrowhead Research USD 1.01B 126.11M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Biogen USD 28.05B 263.9M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Dynavax Technologies USD 986.26M 75.73M 2024-12
Gilead Sciences USD 59B 4.47B 2024-12
J&J USD 180.1B 1.82B 2024-12
Novartis USD 102.25B 1.28B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
TG Therapeutics USD 577.69M 8.32M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



TG Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.